BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34477295)

  • 1. Inhibition of CD146 attenuates retinal neovascularization via vascular endothelial growth factor receptor 2 signalling pathway in proliferative diabetic retinopathy.
    Lin J; Cui K; Xu Y; Tang X; Shi Y; Lu X; Yang B; He Q; Yu S; Liang X
    Acta Ophthalmol; 2022 Jun; 100(4):e899-e911. PubMed ID: 34477295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD146/Soluble CD146 Pathway Is a Novel Biomarker of Angiogenesis and Inflammation in Proliferative Diabetic Retinopathy.
    Abu El-Asrar AM; Nawaz MI; Ahmad A; Siddiquei MM; Allegaert E; Gikandi PW; De Hertogh G; Opdenakker G
    Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):32. PubMed ID: 34293080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of 150-kDa oxygen-regulated protein with vascular endothelial growth factor in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Ahmad A; Alam K; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G
    Acta Ophthalmol; 2018 Jun; 96(4):e460-e467. PubMed ID: 29098793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
    Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
    Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
    Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteine-rich 61, a member of the CCN family, as a factor involved in the pathogenesis of proliferative diabetic retinopathy.
    You JJ; Yang CH; Chen MS; Yang CM
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3447-55. PubMed ID: 19264885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression and activity of 12-lipoxygenase in oxygen-induced ischemic retinopathy and proliferative diabetic retinopathy: implications in retinal neovascularization.
    Al-Shabrawey M; Mussell R; Kahook K; Tawfik A; Eladl M; Sarthy V; Nussbaum J; El-Marakby A; Park SY; Gurel Z; Sheibani N; Maddipati KR
    Diabetes; 2011 Feb; 60(2):614-24. PubMed ID: 21228311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoprotegerin Is a New Regulator of Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy.
    Abu El-Asrar AM; Struyf S; Mohammad G; Gouwy M; Rytinx P; Siddiquei MM; Hernández C; Alam K; Mousa A; De Hertogh G; Opdenakker G; Simó R
    Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):3189-3201. PubMed ID: 28654984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant lncRNA expression in patients with proliferative diabetic retinopathy: preliminary results from a single-center observational study.
    Zeng L; Zhou M; Wang X; Long X; Ye M; Yuan Y; Tan W
    BMC Ophthalmol; 2023 Mar; 23(1):94. PubMed ID: 36899334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of angiopoietin-like protein 8 correlates with VEGF in patients with proliferative diabetic retinopathy.
    Lu Q; Lu L; Chen W; Lu P
    Graefes Arch Clin Exp Ophthalmol; 2017 Aug; 255(8):1515-1523. PubMed ID: 28456825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis.
    Abu El-Asrar AM; Nawaz MI; De Hertogh G; Alam K; Siddiquei MM; Van den Eynde K; Mousa A; Mohammad G; Geboes K; Opdenakker G
    Mol Vis; 2014; 20():1209-24. PubMed ID: 25253987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
    You JJ; Yang CH; Huang JS; Chen MS; Yang CM
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Simó R; Lecube A; Segura RM; García Arumí J; Hernández C
    Am J Ophthalmol; 2002 Sep; 134(3):376-82. PubMed ID: 12208249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CORRELATION OF INCREASED INTRAVITREOUS WNT3A WITH VASCULAR ENDOTHELIAL GROWTH FACTOR IN PROLIFERATIVE DIABETIC RETINOPATHY.
    Gao X; Ma K; Lu N; Hong T; Xu Y; Peng X
    Retina; 2016 Apr; 36(4):812-8. PubMed ID: 26418446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Mohammad G; Allegaert E; Ahmad A; Siddiquei MM; Alam K; Gikandi PW; De Hertogh G; Opdenakker G
    Mol Vis; 2018; 24():394-406. PubMed ID: 29853773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble CD146 boosts therapeutic effect of endothelial progenitors through proteolytic processing of short CD146 isoform.
    Stalin J; Harhouri K; Hubert L; Garrigue P; Nollet M; Essaadi A; Muller A; Foucault-Bertaud A; Bachelier R; Sabatier F; Pisano P; Peiretti F; Leroyer AS; Guillet B; Bardin N; Dignat-George F; Blot-Chabaud M
    Cardiovasc Res; 2016 Aug; 111(3):240-51. PubMed ID: 27170199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreous high expression level of netrin-1 in patients with proliferative diabetic retinopathy.
    Liu J; Xia X; Xiong S; Le Y; Xu H
    Eye Sci; 2011 Jun; 26(2):85-90, 120. PubMed ID: 21692205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Succinate increases in the vitreous fluid of patients with active proliferative diabetic retinopathy.
    Matsumoto M; Suzuma K; Maki T; Kinoshita H; Tsuiki E; Fujikawa A; Kitaoka T
    Am J Ophthalmol; 2012 May; 153(5):896-902.e1. PubMed ID: 22265145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated LRP6 levels correlate with vascular endothelial growth factor in the vitreous of proliferative diabetic retinopathy.
    Gao X; Ma K; Lu N; Xu Y; Hong T; Peng X
    Mol Vis; 2015; 21():665-72. PubMed ID: 26120271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.